Aventis Behring L.L.C., a prominent player in the biopharmaceutical industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in the early 2000s, the company has established itself as a leader in the development and production of innovative therapies, particularly in the fields of immunology and haematology. Specialising in high-quality plasma-derived products, Aventis Behring is renowned for its commitment to patient safety and efficacy. Its unique offerings include immunoglobulins and clotting factor concentrates, which are critical for treating various rare diseases. With a strong market position, the company has achieved significant milestones, including regulatory approvals and partnerships that enhance its global reach and impact in the healthcare sector.
We don't have data for Aventis Behring L.L.C., but we can show you information about their parent organization instead.
View parent company